Latest Investments News

New Frontier Minerals has executed a binding option to acquire a 90% interest in the Pomme Rare Earth Element and Niobium project in Quebec, partnering with Metallium to leverage advanced processing technology and expand its critical minerals footprint.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Aguia Resources is poised to commence production at its Tres Estradas phosphate mine with infrastructure nearly complete and key licenses expected imminently. Meanwhile, exploration at the nearby Passo Feio project reveals promising phosphate grades, underpinning a strong market outlook amid global supply constraints.

Aeris Resources has agreed to acquire Peel Mining in a strategic deal that consolidates key copper assets and extends the Tritton mine life to over 10 years. Peel shareholders will receive Aeris shares plus stakes in a new ASX-listed entity holding Peel’s remaining exploration assets.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

Paladin Energy reported a stronger half-year performance with US$138.3 million revenue from uranium sales, a narrowed net loss, and a successful A$400 million equity raise to fund growth projects.

Paladin Energy reported a strong half-year performance with uranium sales revenue climbing to US$138.3 million, driven by ramp-up at its Namibian mine and significant progress on Canadian development projects.

ASX Limited reported robust first-half results with 11.2% revenue growth, while advancing a strategic reset in response to the ASIC Inquiry and pushing forward its technology modernization agenda.

ASX Limited reported robust half-year results with an 11.2% rise in operating revenue and a steady net profit, while advancing its technology upgrade and responding to regulatory scrutiny.

Pro Medicus Limited reported a robust half-year performance, with underlying profit after tax rising by approximately 30%, driven by significant new sales and strategic implementations. The company remains confident in its proprietary technology's resilience against AI disruption while expanding its market footprint.

ASX Limited has announced a fully franked ordinary dividend of AUD 1.018 per share for the half-year ending December 2025, offering shareholders a dividend reinvestment plan with a 2.5% discount.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.